Total
0
Shares
Singular Health Group (ASX:SHG) - Chief Operating Officer, James Hill
Chief Operating Officer, James Hill
Source: The Market Herald
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Singular Health Group (SHG) teams up with CSIRO and Osteopore (OSX) for an artifical intelligence (AI) based tool to make patient-specific 3D cranial implants
  • The company has received $50,000 from CSIRO’s kick-start program to undertake research with the national science agency
  • The program will focus on the development of an AI based tool to automatically generate cranial implants for craniotomies from CT scans
  • Results from the program will be checked by Singular with a dataset provided by Osteopore (OSX)
  • On the market today, Singular was up 20 per cent and is trading at 21 cents per share

Singular Health Group (SHG) will collaborate with CSIRO and Osteopore (OSX) for an artificial intelligence (AI) based tool to make patient-specific 3D cranial implants.

The company has received $50,000 from CSIRO’s kick-start program to undertake research with the national science agency.

The program will focus on the development of an AI-based tool to automatically generate cranial implants for craniotomies from CT scans.

Results from the program will be checked by Singular with a dataset provided by Osteopore (OSX), as part of a recently signed memorandum of understanding (MOU) agreement.

The MOU also includes a comparative study between the existing cranial implant to the new process.

In addition to the $50,000 investment which is being dollar-matched by the CSIRO KickStart program, Singular’s contribution to the MOU includes utilising its 3Dicom Surgical as the software platform for the tool.

Singular Health’s Managing Director, Thomas Hanly, said this project marks an exciting step for the company.

“Too often, advances in medical technology are made without the input of peers to focus on commercial priorities,” Mr Hanly said.

“Working with Osteopore ensures our work and results will be objectively compared with existing techniques and paves the way for future collaborations and commercialisation opportunities. In this space alone, according to Cetas Healthcare (2020), there are an estimated 1.1 million cranial procedures per annum globally.”

On the market today, Singular was up 20 per cent and is trading at 21 cents per share at 1:45 pm AEDT.

SHG by the numbers
More From The Market Herald
APM (ASX:APM) - CEO, Michael Anghie

" APM Human Services (ASX:APM) expands, acquiring Lifecare

APM Human Services International (APM) has acquired physiotherapy and home care group Lifecare for $68 million.
Resonance Health (ASX:RHT)

" Resonance Health (ASX:RHT) submits LiverSmart to FDA

Resonance Health (RHT) has submitted its LiverSmart device to the Food and Drug Administration (FDA) for US regulatory clearance.
Dotz Nano (ASX:DTZ) - CEO, Gideon Shmuel

" Dotz Nano (ASX:DTZ) signs Malaysian distribution deal for COVID-19 tests

Dotz Nano (DTZ) has entered into a distribution agreement with ScienceVision to promote, sell and distribute its COVID-19 virus detection technology in Malaysia.
Kazia Therapeutics (ASX:KZA) - CEO, Dr James Garner

" Kazia Therapeutics (ASX:KZA) releases “positive” second-phase study results for brain cancer treatment

Kazia Therapeutics (KZA) has opened the trading day green after reporting positive final results from a second-phase clinical study of its paxalisib drug